标题
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
作者
关键词
-
出版物
CIRCULATION RESEARCH
Volume 128, Issue 7, Pages 1040-1061
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-04-02
DOI
10.1161/circresaha.121.318051
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cardiotoxic effects of angiogenesis inhibitors
- (2021) Stephen J.H. Dobbin et al. CLINICAL SCIENCE
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort
- (2020) Daniel A Mulrooney et al. BMJ-British Medical Journal
- Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors.
- (2020) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association
- (2020) Daichi Shimbo et al. CIRCULATION
- Association of Hypertension and Blood Pressure With Kidney Cancer Risk
- (2020) Chang Seong Kim et al. HYPERTENSION
- Prevention and treatment of radiotherapy‐induced side effects
- (2020) Lara Barazzuol et al. Molecular Oncology
- Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
- (2020) J.J. Lin et al. ANNALS OF ONCOLOGY
- Vascular toxicity associated with anti-angiogenic drugs
- (2020) Karla B. Neves et al. CLINICAL SCIENCE
- Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
- (2020) Lori J. Wirth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
- (2020) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
- (2020) Joachim Alexandre et al. Journal of the American Heart Association
- Managing toxicities of Bruton tyrosine kinase inhibitors
- (2020) Andrew Lipsky et al. Hematology-American Society of Hematology Education Program
- Arterial hypertension in patients under antineoplastic therapy
- (2019) Vasiliki Katsi et al. JOURNAL OF HYPERTENSION
- Exploring and comparing adverse events between PARP inhibitors
- (2019) Christopher J LaFargue et al. LANCET ONCOLOGY
- New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
- (2019) Daniela Criscuolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies
- (2019) Ahmad Jayedi et al. HEART
- Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
- (2019) Umberto Campia et al. CIRCULATION
- Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
- (2019) Jorie Versmissen et al. CARDIOVASCULAR RESEARCH
- Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
- (2019) Karla B Neves et al. CARDIOVASCULAR RESEARCH
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) Bernard Escudier et al. ANNALS OF ONCOLOGY
- Arterial hypertension in cancer: The elephant in the room
- (2019) Giacomo Tini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
- (2019) Stephen A. Luebker et al. Frontiers in Oncology
- Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study
- (2019) Emily Banks et al. BMC Medicine
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
- (2019) Aristeidis Seretis et al. Scientific Reports
- Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers
- (2019) Jarosław Przybycinski et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study
- (2019) Longfei Lin et al. Journal of Hematology & Oncology
- Hypertension and incident cardiovascular events following ibrutinib initiation
- (2019) Tyler Dickerson et al. BLOOD
- Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats
- (2019) Katrina M Mirabito Colafella et al. CARDIOVASCULAR RESEARCH
- A population-based study of cardiovascular disease mortality risk in US cancer patients
- (2019) Kathleen M Sturgeon et al. EUROPEAN HEART JOURNAL
- Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
- (2019) Mansoor Raza Mirza et al. LANCET ONCOLOGY
- Association between metabolic syndrome and the incidence of gastric cancer: a meta-analysis of cohort studies
- (2019) Zhibin Li et al. Diabetology & Metabolic Syndrome
- Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)
- (2019) Christine B. Ambrosone et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
- (2019) Isabelle Ray-Coquard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2018) Anna B. Catino et al. Circulation-Heart Failure
- FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
- (2018) Gwynn Ison et al. CLINICAL CANCER RESEARCH
- The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer
- (2018) Roberto Iacovelli et al. Clinical Genitourinary Cancer
- Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
- (2018) Paul M. Barr et al. HAEMATOLOGICA
- VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive ProcessesNovelty and Significance
- (2018) Karla B. Neves et al. HYPERTENSION
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Metastatic Prostate Cancer
- (2018) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors
- (2018) Enrico Bronte et al. PHARMACOLOGY & THERAPEUTICS
- Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities
- (2018) Avirup Guha et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients
- (2018) Matthias Totzeck et al. European Journal of Preventive Cardiology
- Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
- (2018) Paul M. Barr et al. HAEMATOLOGICA
- Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors
- (2018) Stephen J H Dobbin et al. HEART
- Sunitinib-induced blood pressure rise does not involve aldosterone
- (2018) Jorie Versmissen et al. JOURNAL OF HYPERTENSION
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease
- (2017) Arvind K. Pandey et al. HYPERTENSION
- Salt Sensitivity of Angiogenesis Inhibition–Induced Blood Pressure RiseNovelty and Significance
- (2017) Stephanie Lankhorst et al. HYPERTENSION
- Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition
- (2017) Rhian M. Touyz et al. HYPERTENSION
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
- (2017) Daniel L. Rolnik et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
- (2017) Fen Liu et al. Oncotarget
- Hypertension and breast cancer risk: a systematic review and meta-analysis
- (2017) Hedong Han et al. Scientific Reports
- Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies
- (2017) Dagfinn Aune et al. Scientific Reports
- Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
- (2016) José Manuel Ordóñez-Mena et al. BMC Medicine
- Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT
- (2016) Z DeFilipp et al. BONE MARROW TRANSPLANTATION
- Vascular Complications of Cancer Chemotherapy
- (2016) Alan C. Cameron et al. CANADIAN JOURNAL OF CARDIOLOGY
- Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
- (2016) Sean A. Virani et al. CANADIAN JOURNAL OF CARDIOLOGY
- Shared Risk Factors in Cardiovascular Disease and Cancer
- (2016) Ryan J. Koene et al. CIRCULATION
- Central Artery Stiffness in Hypertension and Aging
- (2016) Jay D. Humphrey et al. CIRCULATION RESEARCH
- RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
- (2016) Shumei Kato et al. CLINICAL CANCER RESEARCH
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
- (2016) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
- (2016) Dena Ettehad et al. LANCET
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
- (2016) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- Mechanisms and regulation of endothelial VEGF receptor signalling
- (2016) Michael Simons et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients
- (2016) Bo Liu et al. Oncotarget
- Hypertension and risk of prostate cancer: a systematic review and meta-analysis
- (2016) Zhen Liang et al. Scientific Reports
- Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
- (2015) H. Boer et al. ANNALS OF ONCOLOGY
- Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
- (2015) R. R. McKay et al. CLINICAL CANCER RESEARCH
- Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
- (2015) Pooja Ghatalia et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
- (2015) F. Duffaud et al. EUROPEAN JOURNAL OF CANCER
- Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
- (2015) Weijuan Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study
- (2015) Manuela Quaresma et al. LANCET
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk
- (2015) Li-Min Sun et al. MEDICINE
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Hypertension Due to Antiangiogenic Cancer Therapy With Vascular Endothelial Growth Factor Inhibitors: Understanding and Managing a New Syndrome
- (2014) Heather Yvonne Small et al. CANADIAN JOURNAL OF CARDIOLOGY
- Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
- (2014) Ole-Petter R. Hamnvik et al. CANCER
- Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib
- (2014) Stephanie Lankhorst et al. HYPERTENSION
- Hypertension and Obesity and the Risk of Kidney Cancer in 2 Large Cohorts of US Men and Women
- (2014) Kristen M. Sanfilippo et al. HYPERTENSION
- Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study
- (2014) Ayako Watanabe et al. International Journal of Clinical Oncology
- Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
- (2014) Eleni Rapsomaniki et al. LANCET
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study
- (2014) James Larkin et al. LANCET ONCOLOGY
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Prospective Study on Metabolic Risk Factors and Gallbladder Cancer in the Metabolic Syndrome and Cancer (Me-Can) Collaborative Study
- (2014) Wegene Borena et al. PLoS One
- β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
- (2013) E Pasquier et al. BRITISH JOURNAL OF CANCER
- Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats
- (2013) Bart FJ Heijnen et al. HYPERTENSION RESEARCH
- Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
- (2013) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy
- (2013) Hassan Izzedine et al. KIDNEY INTERNATIONAL
- The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients
- (2013) Philip S. Hall et al. JACC-Heart Failure
- Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
- (2013) Kathy H. Fraeman et al. International Journal of Hypertension
- Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib‡
- (2012) S. George et al. ANNALS OF ONCOLOGY
- Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study
- (2012) Jean-Pascal Fournier et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Management of Antiangiogenic Therapy-Induced Hypertension
- (2012) Nilka de Jesus-Gonzalez et al. HYPERTENSION
- Endothelin 1 Activation of Endothelin A Receptor/NADPH Oxidase Pathway and Diminished Antioxidants Critically Contribute to Endothelial Progenitor Cell Reduction and Dysfunction in Salt-Sensitive Hypertension
- (2012) Dan-Dan Chen et al. HYPERTENSION
- Multivitamins in the Prevention of Cancer in Men
- (2012) J. Michael Gaziano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenesis of calcineurin inhibitor–induced hypertension
- (2012) Ewout J. Hoorn et al. JOURNAL OF NEPHROLOGY
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition
- (2011) M. Sitki Copur et al. Clinical Colorectal Cancer
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Glucocorticoid-induced hypertension
- (2011) Julie E. Goodwin et al. PEDIATRIC NEPHROLOGY
- Posterior reversible encephalopathy syndrome induced by anti-VEGF agents
- (2011) Camille Tlemsani et al. Targeted Oncology
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer--A Report from the Childhood Cancer Survivor Study
- (2010) L. R. Meacham et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk
- (2010) Glenn N. Levine et al. CIRCULATION
- Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases
- (2010) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors
- (2010) Emily S. Robinson et al. HYPERTENSION
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
- (2010) Mariëtte H.W. Kappers et al. HYPERTENSION
- Inflammation, Immunity, and Hypertension
- (2010) David G. Harrison et al. HYPERTENSION
- Treatment of bevacizumab-induced hypertension by amlodipine
- (2010) Olivier Mir et al. INVESTIGATIONAL NEW DRUGS
- Understanding Radiation-Induced Vascular Disease⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2010) Neal L. Weintraub et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- The ubiquitin-proteasome pathway and endothelial (dys)function
- (2009) K. Stangl et al. CARDIOVASCULAR RESEARCH
- Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
- (2009) M. L. Maitland et al. CLINICAL CANCER RESEARCH
- Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors
- (2009) Marlies H.G. Langenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
- (2008) Pal Pacher et al. AMERICAN JOURNAL OF PATHOLOGY
- Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway
- (2008) Minghua Yu et al. CANCER SCIENCE
- Inhibition of Vascular Endothelial Growth Factor-A Signaling Induces Hypertension: Examining the Effect of Cediranib (Recentin; AZD2171) Treatment on Blood Pressure in Rat and the Use of Concomitant Antihypertensive Therapy
- (2008) J. O. Curwen et al. CLINICAL CANCER RESEARCH
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
- (2008) A. C. Mertens et al. JNCI-Journal of the National Cancer Institute
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood Pressure and Risk of Renal Cell Carcinoma in the European Prospective Investigation into Cancer and Nutrition
- (2007) S. Weikert et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
- (2007) J.-J. Mourad et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started